Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Immunology

  • Subscribe to feed (RSS)

Showing page 162 of 175 pages of list content

  • An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19

    This article's authors
    1. Julia Y. Wang
    2. Wei Zhang
    3. Michael W. Roehrl
    4. Victor B. Roehrl
    5. Michael H. Roehrl
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Feb 22, 2021
  • Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected During the 2020 Pandemic

    This article's authors
    1. Maria R. Farcet
    2. Michael Karbiener
    3. Julia Schwaiger
    4. Reinhard Ilk
    5. Thomas R. Kreil
    This article has 1 evaluations Latest evaluation on Feb 15, 2021 Published on Feb 12, 2021
  • Potent in vitro Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain

    This article's authors
    1. Huan Ma
    2. Weihong Zeng
    3. Xiangzhi Meng
    4. Xiaoxue Huang
    5. Yunru Yang
    6. Dan Zhao
    7. Peigen Zhou
    8. Xiaofang Wang
    9. Changcheng Zhao
    10. Yong Sun
    11. Peihui Wang
    12. Huichao Ou
    13. Xiaowen Hu
    14. Yan Xiang
    15. Tengchuan Jin
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Feb 3, 2021
  • A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates

    This article's authors
    1. Annette B. Vogel
    2. Isis Kanevsky
    3. Ye Che
    4. Kena A. Swanson
    5. Alexander Muik
    6. Mathias Vormehr
    7. Lena M. Kranz
    8. Kerstin C. Walzer
    9. Stephanie Hein
    10. Alptekin Güler
    11. Jakob Loschko
    12. Mohan S. Maddur
    13. Kristin Tompkins
    14. Journey Cole
    15. Bonny G. Lui
    16. Thomas Ziegenhals
    17. Arianne Plaschke
    18. David Eisel
    19. Sarah C. Dany
    20. Stephanie Fesser
    21. Stephanie Erbar
    22. Ferdia Bates
    23. Diana Schneider
    24. Bernadette Jesionek
    25. Bianca Sänger
    26. Ann-Kathrin Wallisch
    27. Yvonne Feuchter
    28. Hanna Junginger
    29. Stefanie A. Krumm
    30. André P. Heinen
    31. Petra Adams-Quack
    32. Julia Schlereth
    33. Christoph Kröner
    34. Shannan Hall-Ursone
    35. Kathleen Brasky
    36. Matthew C. Griffor
    37. Seungil Han
    38. Joshua A. Lees
    39. Ellene H. Mashalidis
    40. Parag V. Sahasrabudhe
    41. Charles Y. Tan
    42. Danka Pavliakova
    43. Guy Singh
    44. Camila Fontes-Garfias
    45. Michael Pride
    46. Ingrid L. Scully
    47. Tara Ciolino
    48. Jennifer Obregon
    49. Michal Gazi
    50. Ricardo Carrion
    51. Kendra J. Alfson
    52. Warren V. Kalina
    53. Deepak Kaushal
    54. Pei-Yong Shi
    55. Thorsten Klamp
    56. Corinna Rosenbaum
    57. Andreas N. Kuhn
    58. Özlem Türeci
    59. Philip R. Dormitzer
    60. Kathrin U. Jansen
    61. Ugur Sahin
    This article has 2 evaluations Latest evaluation on Mar 1, 2021 Published on Sep 8, 2020
  • Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2

    This article's authors
    1. Catherine F Hatton
    2. Rachel A Botting
    3. Maria Emilia Dueñas
    4. Iram J Haq
    5. Bernard Verdon
    6. Benjamin J Thompson
    7. Jarmila Stremenova Spegarova
    8. Florian Gothe
    9. Emily Stephenson
    10. Aaron I Gardner
    11. Sandra Murphy
    12. Jonathan Scott
    13. James P Garnett
    14. Sean Carrie
    15. Jason Powell
    16. C M Anjam Khan
    17. Lei Huang
    18. Rafiqul Hussain
    19. Jonathan Coxhead
    20. Tracey Davey
    21. A John Simpson
    22. Muzlifah Haniffa
    23. Sophie Hambleton
    24. Malcolm Brodlie
    25. Chris Ward
    26. Matthias Trost
    27. Gary Reynolds
    28. Christopher J A Duncan
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Sep 9, 2021
  • T-cell Repertoire Characteristics of Asymptomatic and Re-detectable Positive COVID-19 Patients

    This article's authors
    1. Jianhua Xu
    2. Yaling Shi
    3. Yongsi Wang
    4. Yuntao Liu
    5. Dongzi Lin
    6. Jiaqi Zhang
    7. Jing Lin
    8. Wei Hu
    9. Haolan He
    10. Wei Wang
    11. Wentao Fan
    12. Linlin Li
    13. Hai Lan
    14. Chunliang Lei
    15. Kejian Wang
    16. Dawei Wang
    This article has 1 evaluations Latest evaluation on Mar 15, 2021 Published on Mar 4, 2021
  • An effective, safe and cost-effective cell-based chimeric vaccine against SARS-CoV2

    This article's authors
    1. Zhenguo Cheng
    2. Danhua Zhang
    3. XiaoWen Liu
    4. Jinxin Miao
    5. Jianyao Wang
    6. Haoran Guo
    7. Wenli Yan
    8. Zhe Zhang
    9. Na Zhang
    10. Jingjing Wang
    11. Shuangshuang Lu
    12. Zhongxian Zhang
    13. Wei Liu
    14. Hong Liu
    15. Yi Zhang
    16. Lirong Zhang
    17. Jianzeng Dong
    18. Nicholas R Lemoine
    19. Yaohe Wang
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Aug 20, 2020
  • Potent neutralization antibodies induced by a recombinant trimeric Spike protein vaccine candidate containing PIKA adjuvant for COVID-19

    This article's authors
    1. Jiao Tong
    2. Chenxi Zhu
    3. Hanyu Lai
    4. Chunchao Feng
    5. Dapeng Zhou
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Feb 17, 2021
  • Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals

    This article's authors
    1. Nina Le Bert
    2. Anthony T Tan
    3. Kamini Kunasegaran
    4. Christine Y L Tham
    5. Morteza Hafezi
    6. Adeline Chia
    7. Melissa Chng
    8. Meiyin Lin
    9. Nicole Tan
    10. Martin Linster
    11. Wan Ni Chia
    12. Mark I-Cheng Chen
    13. Lin-Fa Wang
    14. Eng Eong Ooi
    15. Shirin Kalimuddin
    16. Paul Anantharajal Tambyah
    17. Jenny Guek-Hong Low
    18. Yee-Joo Tan
    19. Antonio Bertoletti
    This article has 2 evaluations Latest evaluation on Mar 1, 2021 Published on May 27, 2020
  • Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost

    This article's authors
    1. Daniel J. Sheward
    2. Marco Mandolesi
    3. Egon Urgard
    4. Changil Kim
    5. Leo Hanke
    6. Laura Perez Vidakovics
    7. Alec Pankow
    8. Natalie L. Smith
    9. Xaquin Castro Dopico
    10. Gerald McInerney
    11. Jonathan M. Coquet
    12. Gunilla B. Karlsson Hedestam
    13. Ben Murrell
    This article has 1 evaluations Latest evaluation on Apr 7, 2021 Published on May 13, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information